Literature DB >> 7982519

Conversion of atrial fibrillation with ajmaline in a pregnant woman with Wolff-Parkinson-White syndrome.

F Mozo de Rosales1, J Moreno, A Bodegas, J C Melchor, L Fernández LLebrez, G Aranguren.   

Abstract

Pregnancy is related to an increased frequency of arrhythmias in asymptomatic patients with Wolff-Parkinson-White syndrome, which might lead to sudden death. A 40-year-old woman, with Wolff-Parkinson-White syndrome which was not diagnosed until pregnancy, presented in the 34th week with an atrial fibrillation, with high risk criteria for ventricular fibrillation. Intravenous ajmaline was given to convert the tachyarrhythmia to sinus rhythm. We obtained an excellent maternal control with no maternal or fetal adverse effects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982519     DOI: 10.1016/0028-2243(94)90155-4

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  3 in total

1.  Enantiospecific total synthesis of the important biogenetic intermediates along the ajmaline pathway, (+)-polyneuridine and (+)-polyneuridine aldehyde, as well as 16-epivellosimine and macusine A.

Authors:  Wenyuan Yin; M Shahjahan Kabir; Zhijian Wang; Sundari K Rallapalli; Jun Ma; James M Cook
Journal:  J Org Chem       Date:  2010-05-21       Impact factor: 4.354

Review 2.  Management of Atrial Fibrillation in Pregnancy.

Authors:  Luca Cacciotti; Ilaria Passaseo
Journal:  J Atr Fibrillation       Date:  2010-10-22

3.  Emergency therapy of maternal and fetal arrhythmias during pregnancy.

Authors:  Hans-Joachim Trappe
Journal:  J Emerg Trauma Shock       Date:  2010-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.